Blinatumomab - a new drug for acute lymphoblastic leukemia

What is it about?

Blinatumomab is a new immunologic treatment available for patients with acute lymphoblastic leukemia (ALL) that has not responded to conventional treatments or has relapsed after previous treatment. This review describes the way blinatumomab works, the clinical trials supporting its use, and a description of side effects and their management. We also review specific concerns related to preparing the drug and giving it to the patient.

Featured Image